Class A medical device registration in Malaysia does not require an annual review. However, there are specific regulatory requirements and periodic reviews associated with the registration that you should be aware of:

Key Points on Review and Renewal

1. Validity Period

   • Registration Validity: The Certificate of Registration issued for a Class A medical device is typically valid for a period of 5 years from the date of issuance. This means that while the device does not need to be reviewed annually, the registration itself has a set validity period.

2. Renewal Process

   • Before Expiration: To maintain the registration, you must apply for renewal before the certificate expires. The renewal application will require submission of updated documentation and proof of continued compliance with regulatory requirements.
   • Submission: The renewal application is usually submitted through the MeDC@St system, similar to the initial registration process.

3. Post-Market Surveillance

   • Ongoing Monitoring: Even though the registration does not require annual reviews, the device is subject to post-market surveillance. This involves monitoring the device’s performance and safety in the market. Manufacturers must report any adverse events or issues related to the device.

4. Regulatory Changes

   • Compliance with Updates: Ensure that your device continues to comply with any updates to regulatory requirements or standards. If there are significant changes in regulations or standards, you may need to update your documentation or notify the MDA.

5. Changes to the Device

   • Notification: Inform the MDA of any significant changes to the device, such as modifications to design or manufacturing processes. Significant changes may require re-evaluation or an update to the registration.

Summary

• Annual Review: Not required for Class A medical device registration.
• Registration Validity: Typically valid for 5 years.
• Renewal: Apply for renewal before the certificate expires.
• Post-Market Surveillance: Continuous monitoring and reporting of adverse events.
• Regulatory Compliance: Adhere to updates and notify MDA of significant changes.

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn